// App-Quantinova.ai

e23026 : Predicting long-term prognosis using targeted cell free DNA sequencing in resectable pancreatic cancer patients.

Researchers

Presenter

  • Bo Song

Principal Investigators

  • Ling Fung Paul Tang

  • Grace Q. Zhao

  • Shengrong Lin

  • Kang Ying

  • Gang Jin

Medical Centers

  • Chang Hai Hospital, Shanghai, China

  • AccuraGen, Palo Alto, CA

  • AccuraGen, Menlo Park, CA

  • AccuraGen, Shanghai, China

  • Changhai Hospital of Shanghai, Shanghai, China

Locations

  • United States

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Pancreatic cancer

Biomarkers

  • KRAS proto-oncogene, GTPase

  • Plasma cell-free DNA

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved